
MelenhorstLab
@MelenhorstLab
Followers
221
Following
398
Media
2
Statuses
140
Multinational team focused on curing cancer with cell therapy & immuno-engineering. Product safety, efficacy, reproducibility, and affordability are key.
Cleveland, OH
Joined January 2022
RT @GuedanS: 👏 Congrats to Prof. @carlhjune on receiving the @AbarcaPrize! His pioneering work in CAR-T therapy has transformed cancer trea….
0
2
0
RT @WickstromLab: Excited to share our latest work on an image analysis paradigm that combines cell state and morphology analyses of patien….
0
82
0
RT @TylerAlban1: Super cool to see our work highlighted by @ACIR_org If you haven’t had a chance to check it out yet this is a great summar….
0
4
0
RT @dana_peer: Super excited to share the final publication of Spectra, fruit of the wonderful collaboration between .@russell_kunes and @….
0
62
0
North Korea tensions: Why is Kim Jong-un upping the pressure? Not so super, man!
bbc.co.uk
As the Koreas trade warning shots, the situation on the peninsula is at its most volatile in years.
0
0
0
RT @jamecancerdoc: We are looking for doctors who are interested in Hematology and Oncology Hospitalist positions @ClevelandClinic
https://….
0
16
0
RT @GeneCollector: Here is an alternative to BioRender that is TRULY FREE and actively maintained. Over 1500 vector….
0
814
0
I wouldn’t say “starting” but “advancing our understanding. ”. Great progress with high translational potential!
statnews.com
“As you engineer your CAR-T cells, you can make sure they’re not fighting against each other,” a cancer researcher suggests in light of new findings.
0
2
7
RT @WangXiaoLab: Excited to share TEMPOmap, our new spatiotemporal transcriptomics method that integrates metabolic labeling with 3D in sit….
biorxiv.org
Spatiotemporal regulation of the cellular transcriptome is crucial for proper protein expression and cellular function[1][1]. However, the intricate subcellular dynamics of RNA synthesis, decay,...
0
67
0
RT @CleClinicNews: Cleveland Clinic is selected as the leading healthcare system in a new initiative to accelerate collaboration and innova….
0
17
0
RT @GeneCollector: Applications open for a pediatric oncology physician scientist. Pediatric neuro-oncology focused clinical practice and l….
0
8
0
RT @Chrystal_Paulos: CAR-T Day in Lille France has been a wonderful meeting. Highly recommended! @MelenhorstLab @PaulosLab @KlebanoffL….
0
5
0
Interesting work from Scholler, Galon and colleagues on the baseline and post-CAR T cell treatment tumor microenvironment analysis. Plenty of material for mechanistic studies. Congrats to the team!
nature.com
Nature Medicine - Analysis of tumor biopsies from the pivotal phase 1/2 ZUMA-1 trial identifies pre-treatment T cell–related characteristics that are associated with clinical response and...
1
13
60
RT @humanimmunenews: Collaborators at @UPennIBI and @YaleBME unveiled molecular mechanisms ⚙️ that may inform strategies to boost specific….
0
2
0
RT @KlebanoffLab: Impressive phase 1 trial results testing a Claudin18.2-specific CAR in patients with R/R #GImalignancies. Favorable toxic….
0
7
0